title: Response to the Letter to the Editor 'Risks and Benefits of Mucosal Healing with Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic that Needs Careful Evaluation'.
authors.affiliation: Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Italy.
authors.forename: Federica
authors.initials: F
authors.lastname: Nuti
authors.affiliation: Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Italy.
authors.forename: Fortunata
authors.initials: F
authors.lastname: Civitelli
authors.affiliation: Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Italy.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Cucchiara
mesh_terms: D002648:Child; D003424:Crohn Disease; D006801:Humans; D000069285:Infliximab; D018570:Risk Assessment
chemical_list: D000069285:Infliximab